Pluristem Therapeutics, Inc. (NASDAQ:PSTI) shares fell -4.48% in last trading session and ended the day at $1.28. PSTI Gross Margin is 96.70% and its has a return on assets of -37.50%. Pluristem Therapeutics, Inc. (NASDAQ:PSTI) quarterly performance is -14.67%.
Pluristem Therapeutics, Inc. (NASDAQ:PSTI) provides an overview of the Pluristem Therapeutics Inc. ’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pluristem Therapeutics Inc., complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Full House Resorts Inc. (NASDAQ:FLL) ended the last trading day at $1.41. Company weekly volatility is calculated as 3.08% and price to cash ratio as 1.92.
Full House Resorts Inc. (NASDAQ:FLL) announced that the Colorado Limited Gaming Control Commission has granted the Company licenses for its pending acquisition of Bronco Billy’s Casino and Hotel in Cripple Creek, Colorado. The Company expects to close on its acquisition of Bronco Billy’s before the end of the first quarter of 2016 once it has received all regulatory approvals, besides those from Colorado, and in conjunction with the refinancing of its primary debt.
On 23 February, eGain Corporation (NASDAQ:EGAN) shares advanced 1.63% and was closed at $3.74. eGain Corporation (NASDAQ:EGAN) year to date (YTD) performance is -12.21%.
eGain Corp (NASDAQ:EGAN) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, Analyst Ratings Network.com reports. The firm currently has a $4.25 price objective on the stock. Zacks Investment Research‘s price target would indicate a potential upside of 13.64% from the company’s previous close.
TrovaGene, Inc. (NASDAQ:TROV) shares advanced 6.11% in last trading session and ended the day at $4.86. TROV Gross Margin is -33.30% and its has a return on assets of -50.80%. TrovaGene, Inc. (NASDAQ:TROV) quarterly performance is -17.21%.
TrovaGene, Inc. (NASDAQ:TROV) announced that it has entered into an Agreement with Fortified Provider Network (Fortified), a direct-contracted preferred provider network administering benefits nationally for over 4 million covered lives. Based on the agreement, Trovagene’s Precision Cancer Monitoring® (PCM) services are covered as an in-network participating laboratory provider for members of Fortified’s network, which includes self-funded employer groups, insurance carriers and regional and local provider networks that process end-user patient claims.
Pulmatrix, Inc. (NASDAQ:PULM) caters to the Healthcare space. Its performance is -5.88%. On the last day of trading company shares ended up at $2.32. Pulmatrix, Inc. (NASDAQ:PULM) distance from 50-day simple moving average (SMA50) is -4.65%.
On 16 February, Pulmatrix, Inc. (NASDAQ:PULM) and Capsugel have formed a collaboration to develop novel inhaled therapeutics to treat serious pulmonary diseases. The agreement provides Capsugel exclusive rights to manufacture clinical trial and commercial batches of iSPERSE™-based inhaled therapeutic candidates being developed by Pulmatrix and its potential development partners.
Leave a Reply